Skip to main content
Premium Trial:

Request an Annual Quote

Illumina: Apr 22, 2004

Premium

Illumina last week began shipping its BeadStation 500G DNA-analysis platform. The instrument, which uses the company’s SNP-genotyping technology, can analyze samples on either of two bead-based Illumina array platforms: the 16-sample Sentrix BeadChip and the 96-sample Array Matrix. Cost for the platform begins at $250,000 [see the 11/13/03 Pharmacogenomics Reporter].

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.